These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-000615-99 Freiburger ZNS-NHL Studie Therapie für Patienten mit primären Non-Hodgkin Lymphomen des ZNS – Sequentielle Hochdosis-Chemotherapie mit autologer peripherer Blutstammzelltransplantation 2015-03-02 due-trials
Reported results 2005-000663-26 Immunsuppressive Therapy in Duchenne Muscular Dystrophy 2008-04-30 due-trials
Reported results 2005-003812-31 Niaspan in combination with fluvastatin compared to fluvastatin-monotherapy fpr patients with metabolic syndrome 2009-02-27 due-trials
Reported results 2006-000222-31 Vergleich einer strukturierten störungsspezifischen Gruppenpsychotherapie plus Placebo oder Methylphenidat versus einer psychiatrischen Beratung plus Placebo oder Methylphenidat bei ADHS im Erwachsen... 2013-03-07 due-trials
Reported results 2006-002207-13 Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents – a placebo controlled, randomized, double blind clinical trial 2009-12-21 due-trials
Reported results 2006-005906-30 The effect of Ezetimibe 10 mg, Simvastatin 20 mg and the Combination of Simvastatin 20 mg plus 10 mg Ezetimibe on LDL-Subfractions in patients with Type 2 Diabetes (Die Wirkung einer Monotherapie mit ... 2010-05-19 due-trials
Exempt 2007-001892-12 Everolimus and mycophenolate as GvHD-prophylaxis in the allogenous blood stem cell transplantation (Everolimus und Mycophenolsäure als GvHD-Prophylaxe in der allogenen Blutstammzelltransplantation) not-yet-due
Ongoing 2007-004990-24 Comparison of the concentrations of the antibiotic compound Daptomycin in serum, cartilage-, muscle and subcutaneous tissue after a preoperative intravenous administration (Klinische Studie zum Ver... not-yet-due
Reported results 2007-006516-31 Triple arm, prospective-randomised multi centre study phase IV to evaluate calcineurin inhibitor reduced, steroid free immunosuppression after renal transplantation in low-risk patients (HARMONY-Study... 2014-07-31 due-trials
Ongoing 2007-006914-41 Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus escitalopram in chronic major depression with and without early trauma not-yet-due
Reported results Terminated 2008-001833-87 Use of Palifermin to reduce the duration, frequency and severity of oral mucositis after high dose therapy with BEAM and autologous peripheral blood stem cell transplantation in patients with malign l... 2011-06-30 due-trials
Reported results 2008-007645-31 Freiburger Studie zur Behandlung von Primären ZNS-Lymphomen bei Patienten über 65 Jahre: Methotrexat-basierte Chemo-Immuntherapie mit anschließender Erhaltungstherapie - PRIMAIN-Studie - 2015-03-02 due-trials
Reported results 2009-009916-33 Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic ac... 2016-07-13 due-trials
Reported results 2010-018624-20 Tolerance of virucidal alcohol-based hand rubs - healthy volunteer trial 2011-01-17 due-trials
Completed, but no date 2010-020956-69 Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung bad-data
Not reported 2010-022511-18 Behavioral effects and neural correlates of oxytocin on social attention [Verhaltenseffekte und neuronales Korrelat von Oxytocin im Kontext sozialer Aufmerksamkeit] 2019-12-31 due-trials
Exempt, with results 2011-000388-28 Safety of Vorinostat in combination with Bortezomib, Doxorubicin and Dexamethasone (VBDD) in patients with refractory or relapsed multiple myeloma 2015-12-01 not-yet-due
Ongoing 2012-003281-40 Efficacy of gencydo nasal spray on early nasal response after allergen exposition in patients with grass pollen allergy: a randomized, placebo controlled cross over study Wirksamkeit von Gencydo Na... not-yet-due
Reported results 2012-005414-18 Thiotepa- Fludarabine- Treosulfan (TFT) conditioning for 2nd allogeneic PBSCT from a different unrelated donor in patients with AML relapsing from prior allogeneic HCT Konditionierung mit Thiotepa-... 2020-04-17 due-trials
Reported results Terminated 2013-000077-68 Imatinib continuation versus Nilotinib 300 mg twice daily in patients with chronic myeloid leukemia (CML) in chronic phase and major molecular response (MMR) without molecular response ≥ 4.5 log (MR4.... 2018-09-18 due-trials
Reported results 2013-002515-10 Treatment of Optic Neuritis with Erythropoietin: a randomised, double-blind, placebo-controlled trial Behandlung der Optikusneuritis mit Erythropoietin 2019-11-26 due-trials
Ongoing 2013-002539-13 Multicenter randomized double masked parallel design exploratory study to assess safety and efficacy of two different doses of intravitreal anti-VEGF treatment with ranibizumab (0.12 mg vs. 0.20 mg) i... not-yet-due
Not reported 2013-004879-13 α-RT; Phase II open-label study to evaluate the efficacy and safety of Radium-223 dichloride in combination with external beam radiotherapy (EBRT) vs. EBRT alone in the treatment of advanced castrati... 2017-05-30 due-trials
Reported results Terminated 2014-000180-41 Carriage of 3GCREB in patients at risk for relapsing infection: randomized controlled trial of intestinal decolonization with colistin plus rifaximin. Infektionsprävention durch intestinale Dekolon... 2016-12-02 due-trials
Ongoing 2014-001148-40 Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting not-yet-due
Ongoing 2014-001541-24 Neuroenhancement of Interpersonal Psychotherapy in Major Depression Augmentation von Interpersoneller Psychotherapie durch D-Cycloserin not-yet-due
Reported results Terminated 2014-004267-20 Multicenter, randomized Phase 2 Trial to determine the Response Rate of Ruxolitinib and Best Available Treatment (BAT) versus BAT in Steroid-refractory acute Graft-versus-Host Disease (aGvHD) Mult... 2019-11-15 due-trials
Completed, but no date, and reported results 2014-005069-60 R-CPOP as first line therapy for elderly patients with DLBCL and for patients with limited cardiac function with DLBCL bad-data
Reported results 2014-005473-36 Modeling of lipoprotein in patients with familial hypercholesterolemia compared to healthy subjects Modelling der Lipoproteine bei Patienten mit familiärer Hypercholesterinämie im Vergleich zu gesu... 2020-02-05 due-trials
Reported results 2015-002491-24 Safety of Abatacept in patients with interstitial lung disease and common variable immunodeficiency (CVID) and related disease Sicherheit von Abatacept bei der Behandlung von interstitiellen Lungen... 2018-09-26 due-trials
Reported results 2015-003369-27 A Phase I-IIa trial on low-dose IL-2 (Aldesleukin) treatment for immunological dysregulation in common variable immunodeficiency (CVID) Phase I-IIA Studie zu niedrig-dosiertem IL-2 (Aldesleukin) i... 2018-06-05 due-trials
Reported results 2015-003670-32 A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first data on efficacy of losartan in children with recessive dystrophic epidermolysis bullosa (RDEB) Eine... 2021-02-12 due-trials
Ongoing 2015-005071-25 Pharmacodynamic comparison of different oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor in patients undergoing coronary stenting not-yet-due
Completed, report not yet due 2015-005416-15 An open label phase II study of Sirolimus in patients with segmental overgrowth syndrome 2023-07-19 not-yet-due
Reported results 2016-000214-30 Empagliflozin and its effect on heart failure in type 2 diabetes Wirkung von Empagliflozin auf Herzinsuffizienz in Patienten mit Diabetes mellitus Typ 2 2020-11-19 due-trials
Reported results 2016-001628-72 Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients Altersadaptierte Hochdosistherapie gefolgt von autologer Stammzelltransplant... 2021-12-27 due-trials
Reported results 2016-003360-39 Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis Sicherheit und Wirksamkeit von Abatacept bei Patienten mit behandlungsresistenter Sarkoidose 2021-02-15 due-trials
Completed, but no date, and reported results 2016-003551-30 Modeling of the impact of a PCSK9 inhibition on lipoproteins in patients with dyslipidemia Modelling der Auswirkung einer PCSK9 Inhibition auf die Lipoproteine bei Patienten mit Dyslipidämie bad-data
Ongoing 2017-000868-15 Stereotactic Cisternal Lavage in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention of Secondary Brain Injury. A Randomized Controlled Trial. Stereota... not-yet-due
Exempt 2017-002194-18 Phase 1/2 Trial to determine the Response Rate of Nivolumab in Acute Myeloid Leukemia (AML) relapse after Allogeneic Hematopoietic Cell Transplantation (allo-HCT) 2022-11-24 not-yet-due
Ongoing 2017-004219-37 A randomized, prospective, multicenter, controlled and double-blinded Phase II Clinical Trial to evaluate the influence of inhaled Aviptadil on Cough and Quality of Life in Sarcoidosis patients not-yet-due
Ongoing 2017-004570-34 Phase II, Open-label, Study in Patients with anaplastic (ATC) or poorly differentiated thyroid carcinomas (PDTC) to investigate the Clinical Efficacy and Safety of the Combination Therapy of Lenvatini... not-yet-due
Ongoing 2017-004729-34 Effects of transdermal estrogen on Bone Mass in adolescent female patients with Anorexia nervosa (AN) – a placebo-controlled, double-blind, randomized, interventional study „Wirkung von transdermal... not-yet-due
Completed, report not yet due 2018-000017-20 Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) Postoperativer thrombozytenhemmender Effekt von Acetylsalicylsäure bei herzchirurgis... 2023-07-12 not-yet-due
Completed, report not yet due 2019-000972-40 Safety and Efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency Sicherheit und Wirksamkeit von Abatacept (s.c.) in Patienten mit CTLA4 Insuffizi-enz oder LRBA Defizi... 2023-06-28 not-yet-due
Not reported Terminated 2020-000382-16 Efficacy of daratumumab (Dara) retreatment using a histone deacetylase-inhibitor (HDACi: panobinostat) as a Dara-longevity-inducing, epigenetic agent in combination with bortezomib-dexamethasone as ... 2022-06-01 due-trials
Ongoing 2020-001181-10 Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomi... not-yet-due
Reported results Terminated 2020-001408-41 A prospective, randomized, double blinded placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia 2020-08-31 due-trials
Ongoing 2020-001575-33 Low-dose AtropIne for Myopia control in children Niedrig dosiertes Atropin zur Myopie-Kontrolle bei Kindern not-yet-due
Ongoing 2021-001291-42 Radiotherapy in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer Behandlung von Patienten mit einem persi... not-yet-due
Exempt 2021-002073-26 Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steroid-refractory immune related adverse events after immune checkpoint inhibitor therapy Phas... not-yet-due